Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
It's A Drug! It's A Pipeline! It's A New Blockbuster Model!
Forbes
Fri, 03/6/15 - 08:33 am
Pharmacyclics
AbbVie
M&A
Imbruvica
Bored by Golf and Cancer Cured, AbbVie CEO Came Back to Work
Bloomberg
Fri, 03/6/15 - 07:56 am
Richard Gonzalez
Pharma CEOs
AbbVie
Pharmacyclics
M&A
Inside the $21 Billion War for a Blockbuster Cancer Drug
Yahoo/Bloomberg
Fri, 03/6/15 - 07:53 am
AbbVie
Pharmacyclics
M&A
Imbruvica
JNJ
AbbVie’s $21 billion deal for Pharmacyclics — a sign of ‘desperation'?
Fortune
Thu, 03/5/15 - 05:58 pm
AbbVie
Pharmacyclics
M&A
Surprised, stunned and supportive: Analysts assess AbbVie's $21B Pharmacyclics deal
Fierce Biotech
Thu, 03/5/15 - 05:33 pm
AbbVie
Pharmacyclics
Did AbbVie Just Grossly Overpay for Pharmacyclics Inc.?
Motley Fool
Thu, 03/5/15 - 09:38 am
AbbVie
Pharmacyclics
M&A
Imbruvica
Abbvie To Pay $21 Billion For Cancer Biotech Pharmacyclics
Forbes
Thu, 03/5/15 - 08:08 am
AbbVie
Pharmacyclics
M&A
What leads the herd of pharma's biggest cash cows? It's not what you think
Fierce Pharma
Wed, 03/4/15 - 07:01 pm
Celgene
Revlimid
Gilead Sciences
Sovaldi
Humira
AbbVie
Merck touts a bright future in biosimilars with a stable of would-be blockbusters
Fierce Biotech
Wed, 03/4/15 - 09:51 am
Merck
biosimilars
AbbVie
Humira
JNJ
Remicade
Amgen
Enbrel
Samsung Bioepis
Biogen Idec
FDA warning: men's testosterone drugs overused
Yahoo/AP
Wed, 03/4/15 - 08:25 am
FDA
warnings
testosterone
AbbVie
Eli Lilly
Axiron
Androgel
Salix Suitors May Yet Emerge to Challenge Valeant: Real M&A
Bloomberg
Tue, 02/24/15 - 02:23 pm
Salix
Valeant Pharmaceuticals
M&A
Shire
Takeda
AstraZeneca
AbbVie
Actavis
Endo Health Solutions
AbbVie: Amgen Circa 2011?
Barron's
Tue, 02/17/15 - 04:40 pm
Amgen
AbbVie
FirstWord Lists – The best selling drugs in 2014
First Word Pharma
Mon, 02/16/15 - 04:50 pm
Humira
Sovaldi
Remicade
Enbrel
Lantus
Rituxan
Advair
Avastin
Herceptin
Januvia
Merck
AbbVie
Gilead Sciences
JNJ
Amgen
Pfizer
Sanofi
Roche
GSK
Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?
Motley Fool
Mon, 02/16/15 - 10:19 am
Pfizer
Hospira
M&A
Teva Pharmaceutical
AbbVie
Bristol-Myers Squibb
Abbott Labs
Mylan
GSK
Patient groups still think ViiV is tops, with Novo and AbbVie close behind
Fierce Pharma Marketing
Wed, 02/11/15 - 09:47 am
ViiV
Novo Nordisk
AbbVie
patients
AbbVie: Big Pharma at a Discount Price
Barron's
Sat, 02/7/15 - 10:47 am
AbbVie
Gilead Sciences, AbbVie and the End of the Hepatitis-C Trade
Barron's
Sat, 02/7/15 - 10:23 am
Gilead Sciences
AbbVie
hepatitis
hepatitis C
No, the Gilead-AbbVie Price War Won’t Derail the Pharmaceutical Rally
Barron's
Fri, 02/6/15 - 10:30 am
Gilead
AbbVie
drug pricing
hepatitis C
Niche Low-T lifestyle clinics might give suffering Lilly, AbbVie meds a boost
Fierce Pharma Marketing
Thu, 02/5/15 - 09:08 am
testosterone
Eli Lilly
AbbVie
Axiron
Androgel
AbbVie Projects $3B Sales For HCV Cocktail, But Shares Fall 3%
Seeking Alpha
Mon, 02/2/15 - 03:28 pm
AbbVie
hepatitis C
Viekira Pak
Pages
« first
‹ previous
…
57
58
59
60
61
62
63
64
65
…
next ›
last »